AZN vs FOLD · P/E 28, $288.38B cap vs rev $528.3M
AstraZeneca PLC (AZN) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the AZN and FOLD stock pages for the full models.
Not investment advice.